SaxoCell® = Development of new areas of application and production methods for personalized gene and cell therapeutics, so-called »living drugs«. The aim is to produce cells with precisely defined functions and a high safety profile for safe, clinical use on an industrial scale and at socially acceptable costs in order to enable a realistic and sustainable economic model with high value-added potential for the region.
Cluster4Future Innovation Competition
SaxoCell® is one of the winners of the innovation competition “Clusters4Future” of the Federal Ministry of Education and Research (BMBF). Our concept for a Saxon future cluster SaxoCell® in the promising field of cell and gene therapy was selected by an expert jury together with six other projects from a total of 137 applicants in the first competition phase.